Cargando…
Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease
Autores principales: | Schuuring, M. J., van Riel, A. C. M. J., Bouma, B. J., Mulder, B. J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221748/ https://www.ncbi.nlm.nih.gov/pubmed/22081363 http://dx.doi.org/10.1007/s12471-011-0220-3 |
Ejemplares similares
-
Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease
por: Blok, I.M., et al.
Publicado: (2015) -
Adult patients with pulmonary arterial hypertension due to congenital heart disease: a review on advanced medical treatment with bosentan
por: Schuuring, Mark J, et al.
Publicado: (2010) -
Advanced therapy for pulmonary arterial hypertension due to congenital heart disease: a clinical perspective in a new therapeutic era
por: Schuuring, M. J., et al.
Publicado: (2011) -
Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome
por: van Riel, A. C. M. J., et al.
Publicado: (2016) -
The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
por: van Dissel, Alexandra C., et al.
Publicado: (2017)